Addus HomeCare (ADUS) At $35.55 Forms Bottom; Axa Has Raised Kmg Chemicals (KMG) Holding

Addus HomeCare Corporation (ADUS) formed multiple bottom with $32.71 target or 8.00% below today’s $35.55 share price. Addus HomeCare Corporation (ADUS) has $408.84 million valuation. The stock decreased 0.42% or $0.15 during the last trading session, reaching $35.55. About 26,723 shares traded or 2.50% up from the average. Addus HomeCare Corporation (NASDAQ:ADUS) has risen 102.62% since February 21, 2017 and is uptrending. It has outperformed by 85.92% the S&P500.

Axa increased Kmg Chemicals Inc (KMG) stake by 123.76% reported in 2017Q3 SEC filing. Axa acquired 5,600 shares as Kmg Chemicals Inc (KMG)’s stock rose 52.84%. The Axa holds 10,125 shares with $556,000 value, up from 4,525 last quarter. Kmg Chemicals Inc now has $930.79 million valuation. The stock decreased 2.12% or $1.31 during the last trading session, reaching $60.55. About 89,158 shares traded. KMG Chemicals, Inc. (NYSE:KMG) has risen 169.63% since February 21, 2017 and is uptrending. It has outperformed by 152.93% the S&P500.

Axa decreased Incyte Corp (NASDAQ:INCY) stake by 69,036 shares to 203,809 valued at $23.79M in 2017Q3. It also reduced Discover Finl Svcs (NYSE:DFS) stake by 73,450 shares and now owns 106,750 shares. Advanced Energy Inds (NASDAQ:AEIS) was reduced too.

Among 5 analysts covering KMG Chemicals (NYSE:KMG), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. KMG Chemicals has $73 highest and $26 lowest target. $51.50’s average target is -14.95% below currents $60.55 stock price. KMG Chemicals had 9 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was upgraded by Gabelli on Monday, May 1 to “Buy”. Seaport Global Securities upgraded KMG Chemicals, Inc. (NYSE:KMG) on Friday, December 11 to “Buy” rating. The stock of KMG Chemicals, Inc. (NYSE:KMG) earned “Hold” rating by Gabelli on Wednesday, December 14. The firm has “Buy” rating by KeyBanc Capital Markets given on Wednesday, December 13. The stock of KMG Chemicals, Inc. (NYSE:KMG) earned “Strong-Buy” rating by Zacks on Wednesday, August 12. Zacks downgraded the shares of KMG in report on Monday, August 31 to “Hold” rating. The stock of KMG Chemicals, Inc. (NYSE:KMG) has “Neutral” rating given on Wednesday, August 26 by Global Hunter Securities.

Since August 24, 2017, it had 0 buys, and 29 sales for $34.51 million activity. HATCHER DAVID L also sold $505,980 worth of KMG Chemicals, Inc. (NYSE:KMG) on Monday, October 16.

Investors sentiment decreased to 0.95 in Q3 2017. Its down 0.71, from 1.66 in 2017Q2. It dropped, as 14 investors sold KMG shares while 47 reduced holdings. 21 funds opened positions while 37 raised stakes. 8.47 million shares or 0.73% less from 8.53 million shares in 2017Q2 were reported. Driehaus Mgmt Limited owns 24,846 shares. Morgan Stanley has invested 0% in KMG Chemicals, Inc. (NYSE:KMG). Moreover, Northern Tru Corp has 0% invested in KMG Chemicals, Inc. (NYSE:KMG) for 121,392 shares. 5,419 were accumulated by Menta Capital Limited. Bnp Paribas Arbitrage Sa has invested 0% in KMG Chemicals, Inc. (NYSE:KMG). Moreover, Wellington Mngmt Gru Ltd Liability Partnership has 0% invested in KMG Chemicals, Inc. (NYSE:KMG). Moreover, Indexiq Advsr Limited Liability Corporation has 0.04% invested in KMG Chemicals, Inc. (NYSE:KMG). Bridgeway Management Inc holds 0.02% or 26,400 shares in its portfolio. Perritt Cap Mngmt Inc owns 22,806 shares. Schwab Charles Inv Incorporated holds 35,571 shares or 0% of its portfolio. Tiaa Cref Inv Management Limited holds 0% or 61,618 shares in its portfolio. Susquehanna Int Gru Llp has invested 0% in KMG Chemicals, Inc. (NYSE:KMG). Vanguard Group Inc has 407,003 shares. Credit Suisse Ag has invested 0% in KMG Chemicals, Inc. (NYSE:KMG). Victory Capital Mgmt accumulated 2,826 shares.

Since October 9, 2017, it had 0 insider purchases, and 3 sales for $84,405 activity. Shares for $30,743 were sold by BICKHAM W BRADLEY on Wednesday, January 17. Shares for $29,099 were sold by ALLISON R DIRK on Monday, January 22. The insider ZOCCOLI JAMES sold $24,563.

Among 2 analysts covering Addus Homecare (NASDAQ:ADUS), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Addus Homecare has $4500 highest and $31 lowest target. $42.50’s average target is 19.55% above currents $35.55 stock price. Addus Homecare had 4 analyst reports since August 4, 2015 according to SRatingsIntel. The stock has “Hold” rating by Robert W. Baird on Sunday, November 5. The firm has “Buy” rating given on Tuesday, August 29 by Oppenheimer. The firm earned “Outperform” rating on Tuesday, August 4 by Oppenheimer.

Analysts await Addus HomeCare Corporation (NASDAQ:ADUS) to report earnings on March, 5 after the close. They expect $0.38 earnings per share, down 13.64% or $0.06 from last year’s $0.44 per share. ADUS’s profit will be $4.37M for 23.39 P/E if the $0.38 EPS becomes a reality. After $0.38 actual earnings per share reported by Addus HomeCare Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth.